Matches in SemOpenAlex for { <https://semopenalex.org/work/W2306529657> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2306529657 abstract "The PI3K-AKT pathway is hyperactivated in many human cancers, and several drugs to inhibit this pathway are currently being tested in various pre-clinical and clinical trials. It has been shown that pharmacological inhibition of the PI3K-AKT pathway results in feedback activation of other oncogenic signaling pathways, which likely will limit the clinical utilization of these inhibitors in cancer treatment. However, the underlying mechanisms of such feedback regulation remain incompletely understood. The PI3K-AKT pathway is a validated therapeutic target in renal cell carcinoma (RCC). Here we show that FoxO transcription factors serve to promote AKT phosphorylation at Ser473 in response to the treatment of NVP-BEZ235, a PI3K/mTOR dual inhibitor, in renal cancer cells. Inactivation of FoxO attenuated NVP-BEZ235-induced AKT Ser473 phosphorylation, and rendered renal cancer cells more susceptible to NVP-BEZ235-mediated cell growth suppression in vitro and tumor shrinkage in vivo. Mechanistically, we showed that FoxOs upregulated the expression of Rictor, an essential component of mammalian target of rapamycin complex 2 (mTORC2), in response to NVP-BEZ235 treatment, and revealed that Rictor is a key downstream target of FoxOs in NVP-BEZ235-mediated feedback regulation. We also show that FoxOs similarly modulate the feedback response on AKT Ser473 phosphorylation and renal tumor growth by the treatment of other PI3K or AKT inhibitors, such as MK-2206. Together, our study reveals a novel mechanism of PI3K-AKT inhibition-mediated feedback regulation. Importantly, a recent RCC clinical trial with MK-2206 revealed a dichotomous response in renal cancer patients: a subset of patients had dramatic tumor reduction, while another subset of RCC patients showed no decrease in tumor growth rate, and had a very short progression free survival. We will discuss our work to determine the expression/activation status of the FoxO-Rictor-AKT signaling axis in renal cancer patients receiving AKT inhibitor treatment, which may identify FoxO as a novel biomarker to stratify RCC patients for PI3K or AKT inhibitor treatment. Citation Format: Boyi Gan. The roles of FoxO transcription factors in mediating AKT activation and renal tumor growth in response to pharmacological inhibition of the PI3K-AKT pathway. [abstract]. In: Proceedings of the AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer; Sep 14-17, 2014; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2015;14(7 Suppl):Abstract nr B06." @default.
- W2306529657 created "2016-06-24" @default.
- W2306529657 creator A5067510351 @default.
- W2306529657 date "2015-07-01" @default.
- W2306529657 modified "2023-09-27" @default.
- W2306529657 title "Abstract B06: The roles of FoxO transcription factors in mediating AKT activation and renal tumor growth in response to pharmacological inhibition of the PI3K-AKT pathway" @default.
- W2306529657 doi "https://doi.org/10.1158/1538-8514.pi3k14-b06" @default.
- W2306529657 hasPublicationYear "2015" @default.
- W2306529657 type Work @default.
- W2306529657 sameAs 2306529657 @default.
- W2306529657 citedByCount "0" @default.
- W2306529657 crossrefType "proceedings-article" @default.
- W2306529657 hasAuthorship W2306529657A5067510351 @default.
- W2306529657 hasConcept C104317684 @default.
- W2306529657 hasConcept C107846503 @default.
- W2306529657 hasConcept C11960822 @default.
- W2306529657 hasConcept C127561419 @default.
- W2306529657 hasConcept C502942594 @default.
- W2306529657 hasConcept C55493867 @default.
- W2306529657 hasConcept C62478195 @default.
- W2306529657 hasConcept C71924100 @default.
- W2306529657 hasConcept C75217442 @default.
- W2306529657 hasConcept C86554907 @default.
- W2306529657 hasConcept C86803240 @default.
- W2306529657 hasConcept C95444343 @default.
- W2306529657 hasConcept C98490376 @default.
- W2306529657 hasConceptScore W2306529657C104317684 @default.
- W2306529657 hasConceptScore W2306529657C107846503 @default.
- W2306529657 hasConceptScore W2306529657C11960822 @default.
- W2306529657 hasConceptScore W2306529657C127561419 @default.
- W2306529657 hasConceptScore W2306529657C502942594 @default.
- W2306529657 hasConceptScore W2306529657C55493867 @default.
- W2306529657 hasConceptScore W2306529657C62478195 @default.
- W2306529657 hasConceptScore W2306529657C71924100 @default.
- W2306529657 hasConceptScore W2306529657C75217442 @default.
- W2306529657 hasConceptScore W2306529657C86554907 @default.
- W2306529657 hasConceptScore W2306529657C86803240 @default.
- W2306529657 hasConceptScore W2306529657C95444343 @default.
- W2306529657 hasConceptScore W2306529657C98490376 @default.
- W2306529657 hasLocation W23065296571 @default.
- W2306529657 hasOpenAccess W2306529657 @default.
- W2306529657 hasPrimaryLocation W23065296571 @default.
- W2306529657 hasRelatedWork W1006589974 @default.
- W2306529657 hasRelatedWork W1947490328 @default.
- W2306529657 hasRelatedWork W1976744216 @default.
- W2306529657 hasRelatedWork W2024933597 @default.
- W2306529657 hasRelatedWork W2038409460 @default.
- W2306529657 hasRelatedWork W2082935538 @default.
- W2306529657 hasRelatedWork W2091880817 @default.
- W2306529657 hasRelatedWork W2125457616 @default.
- W2306529657 hasRelatedWork W2170126989 @default.
- W2306529657 hasRelatedWork W2182637937 @default.
- W2306529657 hasRelatedWork W2266824813 @default.
- W2306529657 hasRelatedWork W2283206984 @default.
- W2306529657 hasRelatedWork W2317143396 @default.
- W2306529657 hasRelatedWork W2320739410 @default.
- W2306529657 hasRelatedWork W2741501887 @default.
- W2306529657 hasRelatedWork W2946007191 @default.
- W2306529657 hasRelatedWork W2981394621 @default.
- W2306529657 hasRelatedWork W3029562718 @default.
- W2306529657 hasRelatedWork W3030084642 @default.
- W2306529657 hasRelatedWork W3198926699 @default.
- W2306529657 isParatext "false" @default.
- W2306529657 isRetracted "false" @default.
- W2306529657 magId "2306529657" @default.
- W2306529657 workType "article" @default.